Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anika Therapeutics (ANIK)
NASDAQ:ANIK
Anika Therapeutics (ANIK) Stock Price & Analysis
147 Followers
ANIK Stock Chart & Stats
Day’s Range$25.64 - $26.11
52-Week Range― - ―
Previous Close$25.97
Volume49.04K
Average Volume (3M)N/A
Market Cap
$379.71M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 08, 2024EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$37.00Price Target Upside42.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Anika Therapeutics News
Ownership Overview
16.53% Insiders
20.48% Mutual Funds
12.13% Other Institutional Investors
50.86% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ANIK FAQ
What was Anika Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Anika Therapeutics’s market cap?
Currently, no data Available
When is Anika Therapeutics’s upcoming earnings report date?
Anika Therapeutics’s upcoming earnings report date is May 08, 2024 which is in 7 days.
How were Anika Therapeutics’s earnings last quarter?
Anika Therapeutics released its earnings results on Mar 13, 2024. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of -$0.227 by $0.277.
Is Anika Therapeutics overvalued?
According to Wall Street analysts Anika Therapeutics’s price is currently Undervalued.
Does Anika Therapeutics pay dividends?
Anika Therapeutics does not currently pay dividends.
What is Anika Therapeutics’s EPS estimate?
Anika Therapeutics’s EPS estimate is -$0.08.
How many shares outstanding does Anika Therapeutics have?
Currently, no data Available
What happened to Anika Therapeutics’s price movement after its last earnings report?
Anika Therapeutics reported an EPS of $0.05 in its last earnings report, beating expectations of -$0.227. Following the earnings report the stock price went down -3.386%.
Which hedge fund is a major shareholder of Anika Therapeutics?
Among the largest hedge funds holding Anika Therapeutics’s share is Diker Management LLC. It holds Anika Therapeutics’s shares valued at 1M.
---
Anika Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$37.00 (42.91% Upside)
$37.00 (42.91% Upside)
Blogger Sentiment
Neutral
ANIK Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 5.8K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.89%
12-Months-Change
Fundamentals
Return on Equity
-33.21%
Trailing 12-Months
Asset Growth
-17.99%
Trailing 12-Months
Company Description
Anika Therapeutics
Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.
---
ANIK Company Deck
---
ANIK Earnings Call
Q4 2024
0:00 / 0:00
---
ANIK Stock 12 Months Forecast
Average Price Target
$37.00
▲(42.91% Upside)
Technical Analysis
Best Analysts Covering ANIK
1 Year
1 Year Success Rate
7/21 ratings generated profit
1 Year Average Return
-5.00%
reiterated a buy rating 2 months ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -5.00% per trade.
---